Mental Health & Depression: 62 new trials, 3,252 recruiting, 1,353 papers published, May 11–18, Off Label Use tops 3,628 reports.
Doctiplus - We are allways here!
Doctiplus - We are allways here!
Mental Health & Depression: 62 new trials, 3,252 recruiting, 1,353 papers published, May 11–18, Off Label Use tops 3,628 reports.
Cancer & Oncology: 211 new trials, 18,794 recruiting, 3,678 papers published May 11–18, Off Label Use tops 8,596 reports.
Diabetes Type 2: 39 new trials, 1,979 recruiting, 3 Phase 3. Off Label Use leads adverse reports at 10,229. May 11–18.
Heart Disease & Cardiovascular: 139 new trials, 8,712 recruiting, 2,123 papers published May 11–18, Fatigue leads adverse reports at 6,625.
Dementia & Alzheimer’s: 8 new trials, 937 recruiting, 1,365 papers published, May 11–18, 628 death reports.
Mental Health & Depression: 61 new trials, 3 Phase 3, 3,252 recruiting, May 4–11, 3628 off-label use reports.
Cancer & Oncology: 156 new trials, 18,738 recruiting, 3,407 papers published May 4–11, Off Label Use tops 8,516 reports.
Diabetes Type 2: 35 new trials, 1,980 recruiting, 1,406 papers published. Off Label Use tops adverse reports at 10,229. May 4–11.
Heart Disease & Cardiovascular: 112 new trials, 8,669 recruiting, 1,952 papers published May 4–11, Fatigue tops adverse reports at 6,625.
Dementia & Alzheimer’s: 13 new trials, 936 recruiting, 1,371 papers published, 628 death reports. May 4–11.